What is the clinical benefit of primary site postoperative radiation after neoadjuvant chemotherapy and oncologic surgery for an extremity soft tissue synovial sarcoma in an oligometastatic patient with pulmonary metastases ?

Management of oligometastatic soft tissue sarcoma is an interesting problem without a uniform standard of care. Institutionally, we often treat these patients in the following sequence:

1. neoadjuvant chemo, then
2. neoadjuvant concurrent chemoRT to primary site, then
3. consolidate the oligometastatic sites...